BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8027739)

  • 1. Mechanisms for removal of copper from metallothionein by tetrathiomolybdate.
    Suzuki KT; Yamamoto K; Ogra Y; Kanno S; Aoki Y
    J Inorg Biochem; 1994 May; 54(3):157-65. PubMed ID: 8027739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of selective copper removal by tetrathiomolybdate from metallothionein in LEC rats.
    Ogra Y; Ohmichi M; Suzuki KT
    Toxicology; 1996 Jan; 106(1-3):75-83. PubMed ID: 8571404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outputs of hepatic copper and cadmium stimulated by tetrathiomolybdate (TTM) injection in Long-Evans Cinnamon (LEC) rats pretreated with cadmium, and in Fischer rats pretreated with copper and cadmium.
    Lai YR; Sugawara N
    Toxicology; 1997 Jun; 120(1):47-54. PubMed ID: 9160108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal and efflux of copper from Cu-metallothionein as Cu/tetrathiomolybdate complex in LEC rats.
    Ogra Y; Suzuki KT
    Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):196-204. PubMed ID: 7670851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of tetrathiomolybdate on the copper accumulating in the liver of LEC rats.
    Ogra Y; Suzuki KT
    J Inorg Biochem; 1998 Apr; 70(1):49-55. PubMed ID: 9661287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective removal of copper bound to metallothionein in the liver of LEC rats by tetrathiomolybdate.
    Suzuki KT; Yamamoto K; Kanno S; Aoki Y; Takeichi N
    Toxicology; 1993 Oct; 83(1-3):149-58. PubMed ID: 8248942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of copper-metallothionein/tetrathiomolybdate complex is the first step in removal of Cu from LEC rats.
    Suzuki KT; Ogra Y
    Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):187-95. PubMed ID: 7670850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glutathione depletion on removal of copper from LEC rat livers by tetrathiomolybdate.
    Ogra Y; Miyayama T; Anan Y
    J Inorg Biochem; 2010 Aug; 104(8):858-62. PubMed ID: 20427090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disordered copper metabolism in LEC rats, an animal model of Wilson disease: roles of metallothionein.
    Suzuki KT
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):221-40. PubMed ID: 8556276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of copper from the liver of Long-Evans Cinnamon (LEC) rats by tetrathiomolybdate (TTM) injection: the main excretion route is via blood, not bile.
    Sugawara N; Li D; Sugawara C
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):217-26. PubMed ID: 7994566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate of the insoluble copper/tetrathiomolybdate complex formed in the liver of LEC rats with excess tetrathiomolybdate.
    Ogra Y; Chikusa H; Suzuki KT
    J Inorg Biochem; 2000 Jan; 78(2):123-8. PubMed ID: 10766335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of molybdenum treatments on the distribution of Cu and metallothionein in tissue extracts from rats and sheep.
    Allen JD; Gawthorne JM
    J Inorg Biochem; 1987 Nov; 31(3):161-70. PubMed ID: 3430150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molybdenum and copper kinetics after tetrathiomolybdate injection in LEC rats: specific role of serum albumin.
    Suzuki KT; Ogra Y; Ohmichi M
    J Trace Elem Med Biol; 1995 Oct; 9(3):170-5. PubMed ID: 8605607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion of copper complexed with thiomolybdate into the bile and blood in LEC rats.
    Komatsu Y; Sadakata I; Ogra Y; Suzuki KT
    Chem Biol Interact; 2000 Feb; 124(3):217-31. PubMed ID: 10728780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced synthesis of metallothionein as a possible cause of abnormal copper accumulation in LEC rats.
    Kanno S; Aoki Y; Suzuki JS; Takeichi N; Misawa S; Suzuki KT
    J Inorg Biochem; 1994 Nov; 56(2):117-25. PubMed ID: 7798893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease.
    Klein D; Arora U; Lichtmannegger J; Finckh M; Heinzmann U; Summer KH
    J Hepatol; 2004 Mar; 40(3):409-16. PubMed ID: 15123354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic dispositions of molybdenum and copper after tetrathiomolybdate injection in LEC rats.
    Ogra Y; Ohmichi M; Suzuki KT
    J Trace Elem Med Biol; 1995 Oct; 9(3):165-9. PubMed ID: 8605606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological regulation of copper and selective removal of copper: therapy for Wilson disease and its molecular mechanism].
    Suzuki KT; Ogura Y
    Yakugaku Zasshi; 2000 Oct; 120(10):899-908. PubMed ID: 11082702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of subcutaneous tetrathiomolybdate administration on copper and iron metabolism, including their regional redistribution in the brain, in the Long-Evans Cinnamon rat, a bona fide animal model for Wilson's disease.
    Sugawara N; Ikeda T; Lai YR; Sugawara C
    Pharmacol Toxicol; 1999 May; 84(5):211-7. PubMed ID: 10361977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of copper and metallothionein in toxic milk mice by tetrathiomolybdate, but not deferiprone.
    Czachor JD; Cherian MG; Koropatnick J
    J Inorg Biochem; 2002 Jan; 88(2):213-22. PubMed ID: 11803042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.